Aptevo Therapeutics Inc (APVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Operating Expenses | 6,443 | 6,837 | 5,996 | 7,610 | 6,226 |
| Operating Income | -6,443 | -6,837 | -5,996 | -7,610 | -6,226 |
| Other Income | 87 | 140 | 190 | 61 | 22 |
| Pre-tax Income | -6,356 | -6,697 | -5,806 | -7,549 | -6,204 |
| Net Income Continuous | -6,356 | -6,697 | -5,806 | -7,549 | -6,204 |
| Net Income | $-6,356 | $-6,697 | $-5,806 | $-7,549 | $-6,204 |
| EPS Basic Total Ops | -5.31 | -6.41 | 1,685.94 | -40.11 | -151.29 |
| EPS Basic Continuous Ops | -5.31 | -6.31 | 1,684.36 | -33.53 | -151.29 |
| EPS Diluted Total Ops | -5.31 | -6.41 | 1,685.94 | -40.11 | -151.29 |
| EPS Diluted Continuous Ops | -5.31 | -6.31 | 1,684.36 | -33.53 | -151.29 |
| EPS Diluted Before Non-Recurring Items | -5.31 | -6.41 | N/A | -40.11 | -151.08 |
| EBITDA(a) | $-6,411 | $-6,802 | $-5,915 | $-7,561 | $-6,177 |